Physician profile
Muriel Stoev
NPI 1912009515
$376.46
in general payments reported to CMS, 2019-2025
11 companies · $41.19 in 2025
The $41.19 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.51 · 2020: $69.52 · 2021: $26.11 · 2022: $75.44 · 2023: $40.66 · 2024: $79.03 · 2025: $41.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $160.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $140.64 | 2019-2023 | Breztri |
| Lilly USA, LLC | $51.48 | 2021-2024 | Mounjaro, Zepbound |
| Amarin Pharma, INC. | $31.67 | 2019 | |
| Novartis Pharmaceuticals Corporation | $23.14 | 2022 | |
| Exact Sciences Corporation | $23.03 | 2025 | Cologuard Collection Kit |
| Amgen INC. | $20.43 | 2024 | Otezla, Repatha |
| Novo Nordisk INC | $18.59 | 2024 | Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.16 | 2025 | Jardiance |
| Almatica Pharma LLC | $17.30 | 2023 | Sertraline Hcl, Loreev Xr, Gralise |
| Bayer Healthcare Pharmaceuticals INC. | $17.13 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.89 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muriel Stoev listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.